U.S. federal trademark · Serial No. 97171255
Medical testing services, namely, next generation sequencing tests for diagnosis, prognosis, and treatment of brain cancer and brain tumors; marking, separating, isolating, and sequencing and analysis of human tissue and human brain samples for diagnostic or treatment purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.